Evogene Ltd. · BOATS:EVGN

Evogene Ltd. financial statements

Evogene Ltd.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue3.85M5.58M2.98M1.68M930.0K1.04M753.0K1.75M3.38M6.54M
Cost of revenue4.09M2.38M1.49M909.0K767.0K574.0K334.0K1.45M2.85M5.64M
Gross profit-241.0K3.20M1.49M766.0K163.0K466.0K419.0K295.0K536.0K901.0K
Research and development7.99M12.5M16.2M20.8M21.1M17.3M15.8M14.7M17.0M16.4M
Selling, general and administrative4.29M6.99M5.38M6.48M7.25M5.32M3.77M3.51M3.81M3.89M
Operating income-14.0M-18.8M-22.2M-26.9M-31.0M-24.8M-21.2M-20.0M-21.9M-21.1M
Depreciation and amortization1.14M1.38M1.30M1.51M1.30M1.79M2.40M2.02M2.15M2.28M
EBITDA-12.9M-17.4M-20.9M-25.4M-29.7M-23.0M-18.8M-18.0M-19.8M-18.8M
Interest expense1.93M3.36M928.0K3.33M1.41M2.95M555.0K2.21M1.00M891.0K
Income before tax-13.5M-14.8M-21.9M-29.8M-30.4M-26.2M-19.1M-20.8M-20.8M-19.6M
Income tax1.00K9.00K19.0K90.0K13.0K32.0K24.0K30.0K11.0K36.0K
Net income-8.48M-16.5M-23.9M-26.6M-27.8M-23.4M-18.1M-20.8M-20.8M-19.6M
Earnings per share, basic1.08-2.90-5.20-6.44-0.69-0.83-0.70-0.81-0.81-0.77
Earnings per share, diluted1.08-2.90-5.20-6.44-0.69-0.83

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents13.0M15.3M20.8M29.0M32.3M46.2M34.7M5.81M3.44M3.24M
Short-term investments32.0K10.0K10.3M6.38M21.5M2.00M12.1M48.7M68.3M84.9M
Receivables317.0K1.09M357.0K348.0K281.0K222.0K72.0K160.0K132.0K169.0K
Inventory210.0K1.82M76.0K566.0K92.0K0-894.0K-444.0K-8.33M-13.1M
Current assets15.6M21.6M34.5M37.8M56.9M51.8M49.0M55.5M72.8M89.5M
Property, plant and equipment812.0K1.80M2.46M2.50M2.07M2.07M2.58M3.19M4.79M6.48M
Total assets20.0M39.9M51.1M56.1M76.3M71.9M71.4M58.7M77.6M96.0M
Accounts payable639.0K1.23M1.78M1.04M1.46M863.0K1.00M1.01M1.11M1.33M
Current liabilities3.44M18.7M6.94M5.63M6.88M9.68M5.75M5.43M4.66M5.22M
Long-term debt10.4M10.1M
Total debt2.20M12.9M11.5M11.9M2.67M2.44M2.97M
Total liabilities8.07M25.0M22.4M21.3M12.9M15.0M11.1M8.39M8.22M8.70M
Shareholders' equity-82.0K-1.45M12.1M27.9M53.7M46.0M50.1M50.1M69.4M87.3M
Shares outstanding8.72M6.51M5.08M41.3M41.2M35.6M25.8M25.8M25.8M25.5M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-13.5M-19.7M-21.6M-23.7M-24.7M-19.5M-17.7M-15.2M-15.9M-11.7M
Capital spending-135.0K-626.0K-577.0K-1.17M-847.0K-682.0K-900.0K-374.0K-590.0K-808.0K
Free cash flow-13.6M-20.3M-22.2M-24.8M-25.6M-20.2M-18.6M-15.5M-16.5M-12.5M
Cash from investing17.7M9.62M-4.54M13.3M-20.6M9.41M37.1M17.4M15.2M4.03M
Cash from financing-6.60M4.66M18.2M9.34M30.3M20.4M9.31M297.0K814.0K655.0K
Share buybacks10.0M9.00K683.0K186.0K
Change in cash-2.35M-5.47M-8.21M-3.35M-13.9M11.5M28.9M2.38M199.0K-6.99M